Structured evidence table for Myo-Inositol Blood Glucose Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Myo-Inositol Blood Glucose Randomized Trial | It is identified by increased glycated hemoglobin (HbA1c) or an abnormal oral glucose tolerance test. | 2 | Pérez-Piñero Silvia (2026) | Effects of Specific Carob ( Ceratonia siliqua L.) Liquid Concentrate on Glucose Metabolism in Subjects with Prediabetes: A Randomized Double-Blind Controlled Clinical Trial |
| Myo-Inositol Blood Glucose Randomized Trial | Subjects with prediabetes have a high risk of progressing to diabetes, with an annualized conversion rate of 5–10% []. | 2 | Pérez-Piñero Silvia (2026) | Effects of Specific Carob ( Ceratonia siliqua L.) Liquid Concentrate on Glucose Metabolism in Subjects with Prediabetes: A Randomized Double-Blind Controlled Clinical Trial |
| Myo-Inositol Blood Glucose Randomized Trial | The progression of prediabetes to overt T2DM is facilitated by well-known modifiable risk factors, particularly overweight and obesity, physical inactivity, high blood pressure, hyperlipidemia, poor dietary habits, smoking, and excessive alcohol consumption, which collectively contribute to insulin resistance and metabolic dysfunction [,,,]. | 2 | Pérez-Piñero Silvia (2026) | Effects of Specific Carob ( Ceratonia siliqua L.) Liquid Concentrate on Glucose Metabolism in Subjects with Prediabetes: A Randomized Double-Blind Controlled Clinical Trial |
| Myo-Inositol Blood Glucose Randomized Trial | 1 2 3 4 Prediabetes or intermediate hyperglycemia is characterized by elevated blood glucose levels above the normal range but not high enough to meet the criteria for the diagnosis of diabetes. | 2 | Pérez-Piñero Silvia (2026) | Effects of Specific Carob ( Ceratonia siliqua L.) Liquid Concentrate on Glucose Metabolism in Subjects with Prediabetes: A Randomized Double-Blind Controlled Clinical Trial |
| Myo-Inositol Blood Glucose Randomized Trial | 1 2 3 4 Polycystic ovary syndrome (PCOS) is among the most frequent endocrine disorders in women of reproductive age and is strongly associated with multiple cardiometabolic disturbances. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Myo-Inositol Blood Glucose Randomized Trial | While these approaches can reduce symptoms, they mostly do not address the underlying endocrine or metabolic disturbances and may be associated with adverse effects, including gastrointestinal discomfort, weight gain, and fatigue [,]. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Myo-Inositol Blood Glucose Randomized Trial | Increasing evidence also points to the benefits of curcumin, a polyphenolic compound from turmeric, which down-regulates inflammatory mediators and oxidative stress, thereby improving insulin action []. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
| Myo-Inositol Blood Glucose Randomized Trial | Globally, the condition affects roughly 4-20% of women, underscoring its significance as a public-health concern [,]. | 4 | Muacevic Alexander (2026) | Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review |
Source documents